Quoin Pharmaceuticals
QNRX
3 hedge funds and large institutions have $345K invested in Quoin Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (0%)
25% less funds holding
Funds holding: 4 → 3 (-1)
25% less capital invested
Capital invested by funds: $462K → $345K (-$117K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$54.3K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
+$54.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$124K |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $183K | +$54.3K | +1 | +33% |
|
|
WS
2
Wedbush Securities
Los Angeles,
California
| $81K | +$54.3K | +1 | +100% |
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $44K | – | – | – |
|
4
Citadel Advisors
Miami,
Florida
| $12K | – | – | – |
|
|
TSS
5
Two Sigma Securities
New York
| $9K | – | – | – |
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $8K | – | – | – |
|
7
Citigroup
New York
| $5K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $3K | – | – | – |
|
|
SM
9
Sabby Management
Miami Beach,
Florida
| – | -$124K | -2 | Closed |
|
|
RJFSA
10
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| – | -$6K | – | – |
|
QNRX Hedge Fund Activity: Q3 2019 in Review
3 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q3 2019, worth a combined $345K — down 25% from $462K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of QNRX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $54.3K. The largest seller was Sabby Management, exiting entirely with an estimated $124K sold.
- 3 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q3 2019, down from 4 in Q2 2019.
- Funds reported $345K of Quoin Pharmaceuticals stock for Q3 2019, down 25% quarter-over-quarter.
- 0 funds opened new Quoin Pharmaceuticals positions in Q3 2019 and 1 closed out, a net change of -1 holder.
- The largest Quoin Pharmaceuticals buyer in Q3 2019 was Renaissance Technologies, an estimated $54.3K added.
- The largest Quoin Pharmaceuticals seller in Q3 2019 was Sabby Management, an estimated $124K sold.
Based on aggregated 13F filings for Q3 2019.